Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity treatments continue to improve.
A senior US medic said the risk had led him to think twice before taking them, consider alternatives and only use the lowest ...
Millions of Americans rely on GLP-1 drugs to improve their health, but bad actors are peddling dangerous fakes.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback